Filters

Therapie

Showing results (1851-1860 of 2,458) with videos related to

Pageof 246
Sort By:
Therapie|July 2, 2002
[Results of a French nationwide survey of cutaneous side effects of ketoprofen gel reported between September 1996 and August 2000]G Veyrac, M Paulin, B Milpied, et al.
Therapie|July 2, 2002
[The origins of clinical pharmacology in France]J Dangoumau
Therapie|July 2, 2002
[Tolerance of riluzole in a phase IIIb clinical trial]L Lacomblez, M Dib, V Doppler, et al.
Therapie|August 21, 2002
Preclinical testing for teratogenicity and developmental toxicity: methods and limitationsP C Barrow
Therapie|August 21, 2002
[What are the prospects for pharmacological treatment of prion disease?]K T Adjou, M Seman
Therapie|August 21, 2002
Sirolimus: has it gained from experience with older drugs?D W Holt
Therapie|August 21, 2002
[Methods of evaluation of risks tied to drug exposure during pregnancy. Advantages and limits of epidemiology, interpretation of results]E Robert-Gnansia
Therapie|July 31, 2001
[Fom orphan receptor to novel neuropeptide: an example of reverse pharmacology]J C Meunier
Therapie|July 31, 2001
[Therapeutic drug monitoring (TDM): definitions--vocabulary and concepts]E M Billaud
Therapie|July 31, 2001
[Adverse effects of Disulone; results of the France pharmacovigilance inquiry. Regional Centers of Pharmacovigilance]C Benedetti-Bardet, C Guy, O Boudignat, et al.
Pageof 246

Showing results (1851-1860 of 2,458) with videos related to

Sort By:
Pageof 246
Therapie|July 2, 2002
[Results of a French nationwide survey of cutaneous side effects of ketoprofen gel reported between September 1996 and August 2000]G Veyrac, M Paulin, B Milpied, et al.
Therapie|July 2, 2002
[The origins of clinical pharmacology in France]J Dangoumau
Therapie|July 2, 2002
[Tolerance of riluzole in a phase IIIb clinical trial]L Lacomblez, M Dib, V Doppler, et al.
Therapie|August 21, 2002
Preclinical testing for teratogenicity and developmental toxicity: methods and limitationsP C Barrow
Therapie|August 21, 2002
[What are the prospects for pharmacological treatment of prion disease?]K T Adjou, M Seman
Therapie|August 21, 2002
Sirolimus: has it gained from experience with older drugs?D W Holt
Therapie|August 21, 2002
[Methods of evaluation of risks tied to drug exposure during pregnancy. Advantages and limits of epidemiology, interpretation of results]E Robert-Gnansia
Therapie|July 31, 2001
[Fom orphan receptor to novel neuropeptide: an example of reverse pharmacology]J C Meunier
Therapie|July 31, 2001
[Therapeutic drug monitoring (TDM): definitions--vocabulary and concepts]E M Billaud
Therapie|July 31, 2001
[Adverse effects of Disulone; results of the France pharmacovigilance inquiry. Regional Centers of Pharmacovigilance]C Benedetti-Bardet, C Guy, O Boudignat, et al.
Pageof 246
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies
Jove
Visualize
Contact Us